GALNON TFA(475115-35-6(free base))

TargetMol
Product Code: TAR-T8559
Supplier: TargetMol
CodeSizePrice
TAR-T8559-1mg1mg£177.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8559-2mg2mg£229.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8559-1mL1 mL * 10 mM (in DMSO)£230.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8559-5mg5mg£310.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8559-10mg10mg£434.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8559-25mg25mg£670.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8559-50mg50mg£914.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8559-100mg100mg£1,211.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8559-500mg500mg£2,344.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Galnon is a novel non-peptide galanin receptor agonist (GAL1 and GAL2 with Ki of 11.7 and 34.1 μM respectively).
CAS:
T8559
Formula:
C42H47F3N4O8
Molecular Weight:
92.84
Pathway:
Neuroscience; GPCR/G Protein
Purity:
0.9992
SMILES:
FC(F)(F)C(=O)O.O=C(OCC3c1ccccc1c2ccccc23)N[C@@H](CC4CCCCC4)C(=O)N[C@@H](CCCCN)C(=O)Nc5ccc6c(c5)OC(=O)C=C6C
Target:
Neuropeptide Y Receptor

References

Quynh N T T , Islam S M , Anders Flor?n, et al. Effects of galnon, a non-peptide galanin-receptor agonist, on insulin release from rat pancreatic islets[J]. Biochem Biophys Res Commun, 2005, 328(1):213-220. Mcgowan H W , Schuijers J A , Grills B L , et al. Galnon, a galanin receptor agonist, improves intrinsic cortical bone tissue properties but exacerbates bone loss in an ovariectomised rat model[J]. Journal of musculoskeletal & neuronal interactions, 2014, 14(2):162-172.